Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer

Author： Tsuji Takashi   Sawai Terumitsu   Takeshita Hiroaki   Nakagoe Tohru   Hidaka Shigekazu   Yamaguchi Hiroyuki   Yasutake Toru   Nagayasu Takeshi   Tagawa Yutaka  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.6, 2004-12, pp. : 531-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients

By Machida Nozomu  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 279-284

Springer Publishing Company

Access to resources Recommend Favorite

Oral fluoropyrimidines in the treatment of colorectal cancer

By Meropol N.J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1509-1513

Elsevier

Access to resources Recommend Favorite

Combined Analysis of Dihydropyrimidine Dehydrogenase and Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Carcinoma Patients Treated with Adjuvant Gemcitabine Plus S-1 Chemotherapy after Surgical Resection

By Kondo Naru   Murakami Yoshiaki   Uemura Kenichiro   Sudo Takeshi   Hashimoto Yasushi   Nakashima Akira   Sueda Taijiro  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 646-655

Springer Publishing Company

Access to resources Recommend Favorite

Factors predicting the response to oral fluoropyrimidine drugs: A phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study)

By                

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 437-444

Spandidos Publications

Access to resources Recommend Favorite

Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

By Cunningham D.   James R.D.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 826-834

Elsevier

Access to resources Recommend Favorite